Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
10 hedge funds and large institutions have $1.39M invested in Biostar Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
60% more capital invested
Capital invested by funds: $870K → $1.39M (+$518K)
9% less funds holding
Funds holding: 11 → 10 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$500K |
| 2 |
SIM
Spark Investment Management
New York
|
+$39.4K |
| 3 |
N
Natixis
Paris,
France
|
+$33.5K |
| 4 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
+$27.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$26K |
| 2 |
Citigroup
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $1.09M | +$500K | +31,561 | +69% |
|
|
SIM
2
Spark Investment Management
New York
| $119K | +$39.4K | +2,486 | +42% |
|
|
N
3
Natixis
Paris,
France
| $54K | +$33.5K | +2,115 | +123% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $31K | +$21K | +1,322 | +155% |
|
5
California Public Employees Retirement System
Sacramento,
California
| $26K | – | – | – |
|
|
AL
6
Airain Ltd
St. Peter Port,
Guernsey
| $24K | +$27.2K | +1,716 | New |
|
|
VKH
7
Virtu KCG Holdings
New York
| $22K | -$26K | -1,641 | -52% |
|
|
U
8
UBS
Zurich,
Switzerland
| $10K | +$3.95K | +249 | +56% |
|
9
Morgan Stanley
New York
| $7K | +$7.64K | +482 | +2,008% |
|
10
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
11
Citigroup
New York
| – | -$3K | -183 | Closed |
|
BSPM Hedge Fund Activity: Q1 2014 in Review
10 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q1 2014, worth a combined $1.39M — up 60% from $870K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BSPM and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $500K. The largest seller was Virtu KCG Holdings, cutting an estimated $26K.
- 10 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q1 2014, down from 11 in Q4 2013.
- Funds reported $1.39M of Biostar Pharmaceuticals, Inc. stock for Q1 2014, up 60% quarter-over-quarter.
- 1 fund opened new Biostar Pharmaceuticals, Inc. positions in Q1 2014 and 2 closed out, a net change of -1 holder.
- The largest Biostar Pharmaceuticals, Inc. buyer in Q1 2014 was Renaissance Technologies, an estimated $500K added.
- The largest Biostar Pharmaceuticals, Inc. seller in Q1 2014 was Virtu KCG Holdings, an estimated $26K sold.
Based on aggregated 13F filings for Q1 2014.